Rating Change
Needham reiterated its Buy rating on Hinge Health, Inc. (NYSE:HNGE) on November 03, 2026.
Needham reiterated its Buy rating on Hinge Health, Inc. (NYSE:HNGE) on November 03, 2026.

At publication ·
Hinge Health, Inc. (NYSE:HNGE) · reiterate
At a glance
Needham reiterated its Buy rating on Hinge Health, Inc. (NYSE:HNGE) on November 03, 2026.
Hinge Health, Inc. operates in the Healthcare sector. The stock currently trades at $116.92 with a market capitalization of $3.9B.
Analyst coverage from Needham provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Hinge Health, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Nov 03, 2026 | Evercore ISI Group | Outperform | N/A |
| Nov 03, 2026 | Stifel | Buy | N/A |
| Nov 03, 2026 | Canaccord Genuity | Buy | N/A |
| Nov 03, 2026 | Needham | Buy | N/A |
| Oct 26, 2026 | Stifel | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View HNGE Stock Page
A rating of Buy from Needham reflects the analyst's outlook on Hinge Health, Inc. (NYSE:HNGE). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the HNGE forecast page.
Current market data
NYSE · HNGE
Keep reading